In this patient, should we prescribe only propranolol, or is metoprolol an acceptable alternative beta‑blocker?

Beta-Blocker Selection: Propranolol vs Metoprolol

The choice between propranolol and metoprolol depends critically on the specific clinical indication—propranolol is preferred for thyrotoxicosis, essential tremor, and psychiatric conditions, while metoprolol is acceptable for most cardiovascular indications including hypertension and may offer superior protection in certain acute cardiac scenarios.

Clinical Decision Framework

When Propranolol is Specifically Indicated

For thyrotoxicosis and hyperthyroidism, propranolol is the most widely studied and preferred agent 1. The FDA labeling confirms that metoprolol may mask clinical signs of hyperthyroidism (e.g., tachycardia) and warns that abrupt withdrawal could precipitate thyroid storm 2, but propranolol has the additional benefit of inhibiting peripheral conversion of T4 to the more biologically active T3 1. If your patient has thyroid disease with symptomatic hyperthyroidism, use propranolol.

For essential tremor, propranolol has over 40 years of established use, though metoprolol may be effective in some cases 1. Start with propranolol for tremor unless contraindicated.

For psychiatric conditions including panic disorder, performance anxiety, and post-traumatic stress disorder prophylaxis, propranolol is the standard choice 1. The nonselective beta-blockade appears important for these non-cardiovascular indications.

When Metoprolol is Preferred or Equivalent

For hypertension, both agents are acceptable 1. The guideline notes that beta-1 selective agents like metoprolol are indicated for cardiovascular diseases, while nonselective agents like propranolol target non-cardiovascular tissues 1. Historical data shows both lower blood pressure effectively 3, 4.

For acute myocardial infarction with ongoing ischemia-reperfusion injury, metoprolol may be superior. A 2020 study demonstrated that metoprolol—but not propranolol or atenolol—reduced infarct size (18.0% vs 35.9% for vehicle, p<0.01) through a unique mechanism of disrupting neutrophil infiltration during exacerbated inflammation 5. This represents a non-class effect specific to metoprolol's molecular interaction with the β1 receptor.

However, for electrical storm in ICD patients, propranolol proved superior to metoprolol in a 2018 randomized trial. Propranolol (160 mg/24h) combined with IV amiodarone resulted in 90% of patients being arrhythmia-free at 24 hours versus only 53.3% with metoprolol (200 mg/24h), with a 2.67-fold decreased incidence of ventricular arrhythmic events 6.

Critical Safety Considerations

For patients with bronchospastic disease: Metoprolol's beta-1 selectivity makes it safer than propranolol 2. The FDA labeling states that while patients with bronchospastic disease should generally not receive beta-blockers, metoprolol may be used with caution due to its relative selectivity, using the lowest possible dose 2. Propranolol is contraindicated in asthma/COPD; metoprolol is relatively contraindicated but may be used cautiously if essential.

For pheochromocytoma: Both require alpha-blockade first 2, 7. Never use beta-blockers alone as they can cause paradoxical hypertension.

Withdrawal phenomena differ significantly: A 1982 study showed that after propranolol withdrawal, 6 of 9 patients experienced symptoms (headache, palpitations, tremor) with significant blood pressure overshoot, while after metoprolol, 3 of 8 had symptoms with heart rate overshoot 8. Both require gradual tapering over 1-2 weeks, particularly in coronary artery disease 2, 7.

Common Pitfalls

• Don't assume all beta-blockers are interchangeable: The evidence clearly shows non-class effects, particularly for metoprolol in acute MI 5 and propranolol in electrical storm 6
• Don't use propranolol in reactive airway disease: Its non-selective blockade can provoke severe bronchospasm
• Don't abruptly discontinue either agent: Both FDA labels warn of exacerbation of angina, MI, and ventricular arrhythmias 2, 7
• Don't overlook the T3/T4 conversion benefit: Only propranolol inhibits peripheral thyroid hormone conversion 1

Practical Algorithm

1. Identify the primary indication:

   • Thyrotoxicosis/hyperthyroidism → Propranolol
   • Essential tremor → Propranolol first-line
   • Psychiatric conditions → Propranolol
   • Electrical storm in ICD patients → Propranolol
   • Acute MI with ongoing ischemia → Consider metoprolol
   • Hypertension alone → Either acceptable; metoprolol if lung disease concerns

2. Check for contraindications:

   • Asthma/COPD → Metoprolol only (with extreme caution)
   • Pheochromocytoma → Either, but only after alpha-blockade

3. Consider comorbidities: The 2022 guideline emphasizes that roughly 50 different diseases benefit from beta-blocker treatment, with beta-1 selective agents (metoprolol) generally preferred for cardiovascular conditions and non-selective agents (propranolol) for endocrine and psychiatric disorders 1